News

Aramis Group Announces Recent Share Transactions Summary

Aramis Group Announces Recent Share Transactions Summary

Recent Share Transactions by Aramis Group

Aramis Group has recently disclosed key information regarding its share transactions conducted between January 20 and January 24, in accordance with the authorizations granted for its share buyback program. Such transactions are pivotal for enhancing shareholder value and signal the company's strong position in the market.

Details of Share Purchases

In the specified timeframe, Aramis Group made substantial purchases of its own shares. The purchases were executed under the guidelines set by shareholders to operate on its own shares, reflecting the company's commitment to maintaining a robust balance sheet. Here's a snapshot of the share buybacks:

Transaction Summary

The following transactions were carried out:

Name of the issuerIssuer identifier codeTransaction dateFinancial instrument identifier codeTotal daily volume (in number of shares)Daily weighted average purchase price of sharesMarket
Aramis Group9695002Q984W0T41WB42January 20FR0014003U9411,0027.7768XPAR
Aramis Group9695002Q984W0T41WB42January 23FR0014003U947,0517.7909XPAR
Aramis Group9695002Q984W0T41WB42January 24FR0014003U944,9177.7963XPAR
TOTALFR0014003U9422,9707.7853

These transactions reflect Aramis Group's strategy of reinforcing its share value and are essential for its overall mission of delivering value to stakeholders.

Aramis Group Overview

Aramis Group stands out as a leading player in the European B2C online used car sales sector. The company operates across multiple countries, leveraging its expertise in e-commerce and vehicle refurbishment. Established in 2001, Aramis has progressively transformed the car sales market, with over 110,000 vehicles sold annually and more than 2 billion euros in revenue.

Commitment to Sustainability

The organization's commitment to sustainable mobility is central to its operational framework. By promoting a circular economy through its offerings, Aramis Group is ensuring a positive impact on the environment while providing quality services to its customers. The company currently employs over 2,400 individuals and has established multiple refurbishing centers throughout Europe.

Investor Contact Information

For investors and interested parties, Aramis Group encourages direct communication via the following investor relations contact:

Alexandre Leroy
Head of Investor Relations, Financing and Cash Management
alexandre.leroy@aramis.group
Contact Number: +33 (0)6 58 80 50 24

Frequently Asked Questions

What recent transactions did Aramis Group conduct?

Aramis Group conducted share buybacks from January 20 to January 24, with a total of 22,970 shares purchased.

How does Aramis Group's market presence look?

As a significant player in the used car sales market, Aramis Group is focused on sustainable practices while enhancing shareholder value.

What is the significance of these transactions?

These share transactions highlight Aramis Group's commitment to reinforcing its market position and delivering optimal value to stakeholders.

How can investors get in touch with Aramis Group?

Interested investors can reach out to Alexandre Leroy, Head of Investor Relations, via email at alexandre.leroy@aramis.group.

Where can I find more information about Aramis Group?

Extensive information about Aramis Group, including its operations and strategic initiatives, can be accessed through the company's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Device Transforms Golf Ball Pickup Experience

Updated Category News Views 451

Revolutionary Device Enhances Golf Ball Retrieval Inventors are always looking for ways to simplify tasks and improve our experiences. One innovative creator has unveiled a practical solution for golfers: the BALL PICK. This device addresses a common struggle faced by golfers at all skill levels – the hassle of bending down to pick up golf balls. Imagine a device that...

Continue Reading
HCSC Introduces Simplified Health Care Coverage Alternative

Updated Category News Views 321

HCSC Launches a New Streamlined Health Care Coverage Option Health Care Service Corporation (HCSC) is thrilled to announce a new health plan designed to simplify the healthcare experience for its members. This innovative option is aimed at individuals looking for a more straightforward way to handle their healthcare expenses. Simplified Monthly Billing with No Deductibles...

Continue Reading
Desvelados Mexican Cantina: A Flavorful New Gem in Town

Updated Category News Views 314

Desvelados Mexican Cantina Is Now Open In a vibrant celebration, Desvelados Mexican Cantina has opened its doors, bringing authentic Mexican flavors to the local dining scene. This lively cantina invites food lovers to indulge in an array of mouthwatering dishes, making it the perfect spot for gatherings with friends and family. Dining Experience at Desvelados Upon...

Continue Reading
Promising Results from Arcus Biosciences’ Casdatifan in Cancer Trials

Updated Category News Views 67

Groundbreaking Developments in Cancer Treatment Arcus Biosciences, Inc. (NYSE:RCUS), a leader in biopharmaceutical innovation, has recently presented compelling clinical data regarding their leading candidate, casdatifan, a HIF-2a inhibitor that shows outstanding promise in treating metastatic kidney cancer. The data was shared by Dr. Toni K. Choueiri at a significant...

Continue Reading
Understanding Options Movement in Johnson & Johnson Stock

Updated Category News Views 203

Key Insights on Johnson & Johnson Options Activity Investors are paying close attention to the options market for Johnson & Johnson (NYSE: JNJ), as recent activities indicate a bearish stance among high-profile investors. Understanding these movements can be valuable for retail traders looking to navigate the complexities of stock trading. Recent Options Trends Recently,...

Continue Reading